Randomized Trial: High Power Short Duration Versus Ablation Index
Primary Purpose
Atrial Fibrillation Paroxysmal, Catheter Ablation
Status
Recruiting
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
Pulmonary vein isolation
Sponsored by
About this trial
This is an interventional treatment trial for Atrial Fibrillation Paroxysmal
Eligibility Criteria
Inclusion Criteria:
- Paroxysmal atrial fibrillation
- written informed consent
Exclusion Criteria:
- inability to obtain written informed consent
- persistent atrial fibrillation
Sites / Locations
- Robert Bosch Medical CenterRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
High power - short duration
Standard energy
Arm Description
Pulmonary vein isolation with high power settings of 45 Watts
Pulmonary vein isolation with standard power settings (30 Watts)
Outcomes
Primary Outcome Measures
Single procedure success rate, identified by 48-hours Holder-ECGs every three months
Freedom of any atrial arrhythmia of more than 30 sec during a follow-up period of 12 months after the first procedure.
Secondary Outcome Measures
Procedural data
procedural time
Full Information
NCT ID
NCT05251545
First Posted
January 4, 2022
Last Updated
March 28, 2023
Sponsor
Robert Bosch Medical Center
1. Study Identification
Unique Protocol Identification Number
NCT05251545
Brief Title
Randomized Trial: High Power Short Duration Versus Ablation Index
Official Title
Pulmonary Vein Isolation Using High Power - Short Duration Versus Ablation Index: a Prospective Randomized Trial
Study Type
Interventional
2. Study Status
Record Verification Date
March 2023
Overall Recruitment Status
Recruiting
Study Start Date
September 1, 2021 (Actual)
Primary Completion Date
September 1, 2023 (Anticipated)
Study Completion Date
September 1, 2023 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Robert Bosch Medical Center
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The single procedure success rates of durable pulmonary vein isolation (PVI) for paroxysmal atrial fibrillation (PAF) varies between 80 and 90 %.
This prospective, randomized study investigated the efficacy of pulmonary vein isolation with RF-energy following the CLOSE protocol with standard energy application (30 Watts) versus PVI with RF-energy with high power settings (45 Watts).
Detailed Description
A total number of 176 patients undergoing de-novo catheter ablation for paroxysmal AF are planned to be randomized to two different treatment arms. In group-A patients, PVI was performed with RF-energy with standard power settings of 30 Watts in a temperature-controlled mode.
The ablation procedure in group B was performed with RF-energy with higher power settings of 45 Watts. In both groups the ablation is performed with ablation index (AI) and following the CLOSE protocol (AI and ≤ 6 mm interlesion distance using a surround flow catheter, Biosense Webster Thermocool STSF).
A total of 88 patients are planned to be randomized into each group, the follow-up period will be 12 months after the first procedure.
The primary endpoint is freedom of all atrial arrhythmias after one procedure. The secondary endpoint is procedural time. The third endpoint is safety.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Atrial Fibrillation Paroxysmal, Catheter Ablation
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Investigator
Allocation
Randomized
Enrollment
88 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
High power - short duration
Arm Type
Active Comparator
Arm Description
Pulmonary vein isolation with high power settings of 45 Watts
Arm Title
Standard energy
Arm Type
Active Comparator
Arm Description
Pulmonary vein isolation with standard power settings (30 Watts)
Intervention Type
Other
Intervention Name(s)
Pulmonary vein isolation
Intervention Description
Comparison of power levels in catheter ablation in regard of single procedure success rate (freedom of any atrial arrhythmia with a duration of more than 30 sec. 45 Watts versus standard power levels (30 Watts).
Primary Outcome Measure Information:
Title
Single procedure success rate, identified by 48-hours Holder-ECGs every three months
Description
Freedom of any atrial arrhythmia of more than 30 sec during a follow-up period of 12 months after the first procedure.
Time Frame
1 year
Secondary Outcome Measure Information:
Title
Procedural data
Description
procedural time
Time Frame
1 year
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Paroxysmal atrial fibrillation
written informed consent
Exclusion Criteria:
inability to obtain written informed consent
persistent atrial fibrillation
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Peter Ong, Prof
Phone
004971181010
Email
peter.ong@rbk.de
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Peter Ong, Prof
Organizational Affiliation
Robert Bosch Medical Campus
Official's Role
Principal Investigator
Facility Information:
Facility Name
Robert Bosch Medical Center
City
Stuttgart
ZIP/Postal Code
70376
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Cathrin Theis, MD
Phone
+4971181015518
Email
ctheis@gmx.net
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Randomized Trial: High Power Short Duration Versus Ablation Index
We'll reach out to this number within 24 hrs